| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 5.91e-11 | 188 | 53 | 10 | GO:0005201 | |
| GeneOntologyMolecularFunction | calcium ion binding | MASP1 SCUBE1 FBN1 DLL4 CCBE1 ADGRE3 MATN3 C1R LTBP2 DLL1 NOTCH2 | 3.47e-06 | 749 | 53 | 11 | GO:0005509 |
| GeneOntologyMolecularFunction | structural molecule activity | COL4A1 ZP1 COL4A3 FBN1 FN1 MATN3 LAMA2 KRTAP24-1 LTBP2 TECTA COLQ | 1.79e-05 | 891 | 53 | 11 | GO:0005198 |
| GeneOntologyMolecularFunction | heparin binding | 1.54e-04 | 192 | 53 | 5 | GO:0008201 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 2.47e-04 | 46 | 53 | 3 | GO:0030020 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 7.12e-04 | 268 | 53 | 5 | GO:0005539 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 1.63e-03 | 323 | 53 | 5 | GO:1901681 | |
| GeneOntologyMolecularFunction | Notch binding | 2.33e-03 | 27 | 53 | 2 | GO:0005112 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 5.45e-05 | 377 | 54 | 7 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 5.54e-05 | 378 | 54 | 7 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 5.64e-05 | 379 | 54 | 7 | GO:0045229 | |
| GeneOntologyBiologicalProcess | regulation of fat cell differentiation | 7.74e-05 | 168 | 54 | 5 | GO:0045598 | |
| GeneOntologyBiologicalProcess | response to growth factor | 8.48e-05 | 883 | 54 | 10 | GO:0070848 | |
| GeneOntologyBiologicalProcess | cardiac atrium morphogenesis | 1.05e-04 | 35 | 54 | 3 | GO:0003209 | |
| GeneOntologyBiologicalProcess | developmental growth | 1.10e-04 | 911 | 54 | 10 | GO:0048589 | |
| GeneOntologyBiologicalProcess | cardiac atrium development | 1.81e-04 | 42 | 54 | 3 | GO:0003230 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | COL4A1 COL4A3 FBN1 BMP10 CCBE1 ADGRE3 CSNK2B CHRDL1 LTBP2 DLL1 NOTCH2 | 2.11e-04 | 1186 | 54 | 11 | GO:0007167 |
| GeneOntologyBiologicalProcess | axis specification | 2.19e-04 | 113 | 54 | 4 | GO:0009798 | |
| GeneOntologyBiologicalProcess | circulatory system development | COL4A1 COL4A3 SCUBE1 FBN1 FN1 BMP10 DLL4 CCBE1 KLF5 DLL1 NOTCH2 AXIN2 | 2.85e-04 | 1442 | 54 | 12 | GO:0072359 |
| GeneOntologyBiologicalProcess | marginal zone B cell differentiation | 2.99e-04 | 10 | 54 | 2 | GO:0002315 | |
| GeneOntologyBiologicalProcess | proximal tubule development | 2.99e-04 | 10 | 54 | 2 | GO:0072014 | |
| GeneOntologyBiologicalProcess | cholangiocyte proliferation | 2.99e-04 | 10 | 54 | 2 | GO:1990705 | |
| GeneOntologyBiologicalProcess | cell fate determination | 3.05e-04 | 50 | 54 | 3 | GO:0001709 | |
| GeneOntologyBiologicalProcess | semi-lunar valve development | 3.05e-04 | 50 | 54 | 3 | GO:1905314 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | 3.30e-04 | 850 | 54 | 9 | GO:0071363 | |
| GeneOntologyBiologicalProcess | collagen-activated tyrosine kinase receptor signaling pathway | 4.37e-04 | 12 | 54 | 2 | GO:0038063 | |
| GeneOntologyBiologicalProcess | angiogenesis | 4.77e-04 | 708 | 54 | 8 | GO:0001525 | |
| GeneOntologyBiologicalProcess | renal system development | 5.00e-04 | 386 | 54 | 6 | GO:0072001 | |
| GeneOntologyBiologicalProcess | regulation of osteoclast development | 5.15e-04 | 13 | 54 | 2 | GO:2001204 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | 5.97e-04 | 1125 | 54 | 10 | GO:0035239 | |
| GeneOntologyBiologicalProcess | left/right axis specification | 6.00e-04 | 14 | 54 | 2 | GO:0070986 | |
| GeneOntologyBiologicalProcess | heart valve morphogenesis | 6.03e-04 | 63 | 54 | 3 | GO:0003179 | |
| GeneOntologyCellularComponent | extracellular matrix | COL4A1 ZP1 COL4A3 FBN1 FCGBP FN1 OTOGL CCBE1 MATN3 LAMA2 C1QA LTBP2 TECTA COLQ | 7.97e-10 | 656 | 54 | 14 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL4A1 ZP1 COL4A3 FBN1 FCGBP FN1 OTOGL CCBE1 MATN3 LAMA2 C1QA LTBP2 TECTA COLQ | 8.29e-10 | 658 | 54 | 14 | GO:0030312 |
| GeneOntologyCellularComponent | basement membrane | 7.17e-07 | 122 | 54 | 6 | GO:0005604 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 8.86e-07 | 530 | 54 | 10 | GO:0062023 | |
| GeneOntologyCellularComponent | collagen trimer | 3.17e-06 | 88 | 54 | 5 | GO:0005581 | |
| GeneOntologyCellularComponent | collagen type IV trimer | 9.76e-05 | 6 | 54 | 2 | GO:0005587 | |
| GeneOntologyCellularComponent | basement membrane collagen trimer | 1.82e-04 | 8 | 54 | 2 | GO:0098651 | |
| GeneOntologyCellularComponent | network-forming collagen trimer | 1.82e-04 | 8 | 54 | 2 | GO:0098642 | |
| GeneOntologyCellularComponent | collagen network | 1.82e-04 | 8 | 54 | 2 | GO:0098645 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 2.09e-04 | 332 | 54 | 6 | GO:0005788 | |
| GeneOntologyCellularComponent | complex of collagen trimers | 1.33e-03 | 21 | 54 | 2 | GO:0098644 | |
| HumanPheno | Iridodonesis | 1.65e-06 | 5 | 29 | 3 | HP:0100693 | |
| HumanPheno | Deep anterior chamber | 3.13e-05 | 2 | 29 | 2 | HP:0007765 | |
| HumanPheno | Abnormal vascular morphology | COL4A1 LIMK1 MASP1 FBN1 POLR1A FN1 DLL4 CCBE1 LAMA2 RSPO2 C1R LTBP2 UQCRFS1 DLL1 COLQ SH2D1A CD96 NOTCH2 | 4.13e-05 | 1319 | 29 | 18 | HP:0025015 |
| HumanPheno | Abnormal blood vessel morphology | COL4A1 LIMK1 MASP1 FBN1 POLR1A DLL4 CCBE1 LAMA2 RSPO2 C1R LTBP2 UQCRFS1 DLL1 COLQ SH2D1A CD96 NOTCH2 | 5.24e-05 | 1201 | 29 | 17 | HP:0033353 |
| HumanPheno | Ventricular septal defect | LIMK1 MASP1 FBN1 POLR1A DLL4 CCBE1 RSPO2 LTBP2 UQCRFS1 CD96 NOTCH2 | 5.87e-05 | 510 | 29 | 11 | HP:0001629 |
| HumanPheno | Abnormal ventricular septum morphology | LIMK1 MASP1 FBN1 POLR1A DLL4 CCBE1 RSPO2 LTBP2 UQCRFS1 CD96 NOTCH2 | 7.16e-05 | 521 | 29 | 11 | HP:0010438 |
| HumanPheno | Limitation of joint mobility | 7.95e-05 | 432 | 29 | 10 | HP:0001376 | |
| HumanPheno | Aplasia/hypoplasia involving bones of the hand | MASP1 FBN1 HDAC6 FN1 DLL4 CCBE1 MATN3 RSPO2 LTBP2 CD96 NOTCH2 | 9.63e-05 | 538 | 29 | 11 | HP:0005927 |
| HumanPheno | Abnormality of lens shape | 1.28e-04 | 18 | 29 | 3 | HP:0011526 | |
| HumanPheno | Abnormal cardiac ventricle morphology | LIMK1 MASP1 FBN1 POLR1A DLL4 CCBE1 LAMA2 RSPO2 LTBP2 UQCRFS1 COLQ CD96 NOTCH2 | 1.44e-04 | 780 | 29 | 13 | HP:0001713 |
| HumanPheno | Aplasia/hypoplasia involving bones of the upper limbs | MASP1 FBN1 HDAC6 FN1 DLL4 CCBE1 MATN3 RSPO2 LTBP2 CD96 NOTCH2 | 1.69e-04 | 572 | 29 | 11 | HP:0006496 |
| HumanPheno | Hyperlordosis | 1.86e-04 | 222 | 29 | 7 | HP:0003307 | |
| HumanPheno | Lordosis | 1.86e-04 | 222 | 29 | 7 | HP:0002939 | |
| HumanPheno | Microspherophakia | 1.86e-04 | 4 | 29 | 2 | HP:0030961 | |
| HumanPheno | Abnormal thorax morphology | LIMK1 MASP1 VRK1 FBN1 HDAC6 POLR1A FN1 CCBE1 MATN3 LAMA2 RSPO2 C1R LTBP2 DLL1 COLQ CD96 NOTCH2 | 2.03e-04 | 1328 | 29 | 17 | HP:0000765 |
| HumanPheno | Megalocornea | 2.20e-04 | 54 | 29 | 4 | HP:0000485 | |
| HumanPheno | Anterior chamber mesodermal anomalies | 2.20e-04 | 54 | 29 | 4 | HP:0008040 | |
| HumanPheno | Spherophakia | 3.10e-04 | 5 | 29 | 2 | HP:0034375 | |
| MousePheno | abnormal capillary morphology | 9.22e-06 | 93 | 43 | 5 | MP:0003658 | |
| MousePheno | abnormal artery morphology | 4.98e-05 | 440 | 43 | 8 | MP:0002191 | |
| Domain | EGF-like_dom | MASP1 SCUBE1 FBN1 FCGBP DLL4 CCBE1 ADGRE3 MATN3 LAMA2 C1R LTBP2 TECTA DLL1 NOTCH2 | 5.88e-15 | 249 | 53 | 14 | IPR000742 |
| Domain | EGF_CA | MASP1 SCUBE1 FBN1 DLL4 CCBE1 ADGRE3 MATN3 C1R LTBP2 DLL1 NOTCH2 | 3.53e-14 | 122 | 53 | 11 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | MASP1 SCUBE1 FBN1 DLL4 CCBE1 ADGRE3 MATN3 C1R LTBP2 DLL1 NOTCH2 | 4.23e-14 | 124 | 53 | 11 | IPR001881 |
| Domain | EGF | SCUBE1 FBN1 FCGBP DLL4 CCBE1 ADGRE3 MATN3 LAMA2 C1R LTBP2 TECTA DLL1 NOTCH2 | 7.66e-14 | 235 | 53 | 13 | SM00181 |
| Domain | ASX_HYDROXYL | 1.97e-13 | 100 | 53 | 10 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 3.58e-13 | 106 | 53 | 10 | IPR000152 | |
| Domain | EGF_CA | 2.27e-12 | 86 | 53 | 9 | PF07645 | |
| Domain | EGF_Ca-bd_CS | 6.91e-12 | 97 | 53 | 9 | IPR018097 | |
| Domain | EGF-like_CS | MASP1 SCUBE1 FBN1 FN1 DLL4 CCBE1 MATN3 LAMA2 C1R LTBP2 DLL1 NOTCH2 | 6.91e-12 | 261 | 53 | 12 | IPR013032 |
| Domain | EGF_CA | 8.33e-12 | 99 | 53 | 9 | PS01187 | |
| Domain | EGF_3 | MASP1 SCUBE1 FBN1 DLL4 CCBE1 ADGRE3 MATN3 C1R LTBP2 DLL1 NOTCH2 | 4.74e-11 | 235 | 53 | 11 | PS50026 |
| Domain | EGF_1 | MASP1 SCUBE1 FBN1 FN1 DLL4 CCBE1 LAMA2 C1R LTBP2 DLL1 NOTCH2 | 1.14e-10 | 255 | 53 | 11 | PS00022 |
| Domain | EGF_2 | MASP1 SCUBE1 FBN1 DLL4 CCBE1 MATN3 LAMA2 C1R LTBP2 DLL1 NOTCH2 | 1.72e-10 | 265 | 53 | 11 | PS01186 |
| Domain | Growth_fac_rcpt_ | 5.08e-10 | 156 | 53 | 9 | IPR009030 | |
| Domain | EGF | 1.48e-06 | 126 | 53 | 6 | PF00008 | |
| Domain | Collagen | 4.19e-06 | 85 | 53 | 5 | IPR008160 | |
| Domain | Collagen | 4.19e-06 | 85 | 53 | 5 | PF01391 | |
| Domain | CUB | 1.11e-05 | 49 | 53 | 4 | PF00431 | |
| Domain | CUB | 1.21e-05 | 50 | 53 | 4 | SM00042 | |
| Domain | - | 1.41e-05 | 52 | 53 | 4 | 2.60.120.290 | |
| Domain | CUB | 1.53e-05 | 53 | 53 | 4 | PS01180 | |
| Domain | CUB_dom | 2.04e-05 | 57 | 53 | 4 | IPR000859 | |
| Domain | TILa | 2.37e-05 | 3 | 53 | 2 | PF12714 | |
| Domain | TILa_dom | 2.37e-05 | 3 | 53 | 2 | IPR025615 | |
| Domain | DSL | 4.72e-05 | 4 | 53 | 2 | PF01414 | |
| Domain | Pept_S1A_C1r/C1S/mannan-bd | 4.72e-05 | 4 | 53 | 2 | IPR024175 | |
| Domain | DSL | 4.72e-05 | 4 | 53 | 2 | SM00051 | |
| Domain | DSL | 7.86e-05 | 5 | 53 | 2 | IPR001774 | |
| Domain | DSL | 7.86e-05 | 5 | 53 | 2 | PS51051 | |
| Domain | Notch_ligand_N | 7.86e-05 | 5 | 53 | 2 | IPR011651 | |
| Domain | MNNL | 7.86e-05 | 5 | 53 | 2 | PF07657 | |
| Domain | C4 | 1.18e-04 | 6 | 53 | 2 | SM00111 | |
| Domain | - | 1.18e-04 | 6 | 53 | 2 | 2.170.240.10 | |
| Domain | Collagen_VI_NC | 1.18e-04 | 6 | 53 | 2 | IPR001442 | |
| Domain | C4 | 1.18e-04 | 6 | 53 | 2 | PF01413 | |
| Domain | NC1_IV | 1.18e-04 | 6 | 53 | 2 | PS51403 | |
| Domain | TB | 1.64e-04 | 7 | 53 | 2 | PF00683 | |
| Domain | VWC | 1.70e-04 | 38 | 53 | 3 | SM00214 | |
| Domain | - | 2.19e-04 | 8 | 53 | 2 | 3.90.290.10 | |
| Domain | VWF_dom | 2.29e-04 | 42 | 53 | 3 | IPR001007 | |
| Domain | TB | 2.81e-04 | 9 | 53 | 2 | PS51364 | |
| Domain | TB_dom | 2.81e-04 | 9 | 53 | 2 | IPR017878 | |
| Domain | ZP_dom_CS | 3.50e-04 | 10 | 53 | 2 | IPR017977 | |
| Domain | Sushi | 4.32e-04 | 52 | 53 | 3 | PF00084 | |
| Domain | CCP | 4.83e-04 | 54 | 53 | 3 | SM00032 | |
| Domain | TIL | 5.12e-04 | 12 | 53 | 2 | PF01826 | |
| Domain | C8 | 5.12e-04 | 12 | 53 | 2 | PF08742 | |
| Domain | SUSHI | 5.38e-04 | 56 | 53 | 3 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 5.67e-04 | 57 | 53 | 3 | IPR000436 | |
| Domain | Unchr_dom_Cys-rich | 6.04e-04 | 13 | 53 | 2 | IPR014853 | |
| Domain | C8 | 6.04e-04 | 13 | 53 | 2 | SM00832 | |
| Domain | ZP_1 | 7.03e-04 | 14 | 53 | 2 | PS00682 | |
| Domain | TIL_dom | 7.03e-04 | 14 | 53 | 2 | IPR002919 | |
| Domain | ZP_2 | 7.03e-04 | 14 | 53 | 2 | PS51034 | |
| Domain | ZP | 8.10e-04 | 15 | 53 | 2 | SM00241 | |
| Domain | VWD | 9.24e-04 | 16 | 53 | 2 | SM00216 | |
| Domain | VWF_type-D | 9.24e-04 | 16 | 53 | 2 | IPR001846 | |
| Domain | VWFD | 9.24e-04 | 16 | 53 | 2 | PS51233 | |
| Domain | VWD | 9.24e-04 | 16 | 53 | 2 | PF00094 | |
| Domain | ZP_dom | 1.05e-03 | 17 | 53 | 2 | IPR001507 | |
| Domain | Zona_pellucida | 1.05e-03 | 17 | 53 | 2 | PF00100 | |
| Domain | VWC_out | 1.31e-03 | 19 | 53 | 2 | SM00215 | |
| Domain | RHOD | 1.76e-03 | 22 | 53 | 2 | SM00450 | |
| Domain | RHODANESE_3 | 1.92e-03 | 23 | 53 | 2 | PS50206 | |
| Domain | Rhodanese-like_dom | 2.10e-03 | 24 | 53 | 2 | IPR001763 | |
| Domain | Rhodanese | 2.10e-03 | 24 | 53 | 2 | PF00581 | |
| Domain | - | 2.10e-03 | 24 | 53 | 2 | 3.40.250.10 | |
| Domain | cEGF | 2.46e-03 | 26 | 53 | 2 | IPR026823 | |
| Domain | cEGF | 2.46e-03 | 26 | 53 | 2 | PF12662 | |
| Domain | hEGF | 2.85e-03 | 28 | 53 | 2 | PF12661 | |
| Domain | VWFC_2 | 5.20e-03 | 38 | 53 | 2 | PS50184 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 3.59e-07 | 300 | 45 | 9 | M610 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.36e-06 | 258 | 45 | 8 | MM14572 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 2.04e-06 | 66 | 45 | 5 | M18 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 3.05e-06 | 32 | 45 | 4 | MM14854 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 4.12e-06 | 76 | 45 | 5 | M27219 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 5.54e-06 | 37 | 45 | 4 | M27134 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 6.87e-06 | 39 | 45 | 4 | MM14601 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 8.50e-06 | 13 | 45 | 3 | M47423 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 1.02e-05 | 43 | 45 | 4 | M53 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 1.12e-05 | 44 | 45 | 4 | M26969 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 1.14e-05 | 161 | 45 | 6 | M39770 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 1.37e-05 | 97 | 45 | 5 | MM15926 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 1.66e-05 | 101 | 45 | 5 | M39448 | |
| Pathway | WP_COMPLEMENT_ACTIVATION_CLASSICAL_PATHWAY | 2.00e-05 | 17 | 45 | 3 | MM15944 | |
| Pathway | BIOCARTA_COMP_PATHWAY | 2.00e-05 | 17 | 45 | 3 | MM1369 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 2.99e-05 | 114 | 45 | 5 | MM14571 | |
| Pathway | BIOCARTA_COMP_PATHWAY | 3.34e-05 | 20 | 45 | 3 | M917 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 3.63e-05 | 59 | 45 | 4 | M27218 | |
| Pathway | REACTOME_NOTCH2_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 4.49e-05 | 22 | 45 | 3 | M27210 | |
| Pathway | WP_COMPLEMENT_ACTIVATION | 4.49e-05 | 22 | 45 | 3 | M39502 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 7.98e-05 | 140 | 45 | 5 | M587 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 8.43e-05 | 27 | 45 | 3 | M39545 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 9.83e-05 | 76 | 45 | 4 | MM14867 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 1.16e-04 | 30 | 45 | 3 | M27216 | |
| Pathway | WP_BREAST_CANCER_PATHWAY | 1.25e-04 | 154 | 45 | 5 | M39739 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.41e-04 | 32 | 45 | 3 | MM14924 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_FIBRINOLYTIC_SYSTEM_C1INH | 1.48e-04 | 6 | 45 | 2 | M47882 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SARS_COV_2_S_TO_CLASSICAL_PATHWAY_OF_COMPLEMENT_CASCADE | 1.48e-04 | 6 | 45 | 2 | M47783 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.52e-04 | 85 | 45 | 4 | M16441 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH2 | 1.55e-04 | 33 | 45 | 3 | M604 | |
| Pathway | WP_CANCER_PATHWAYS | 1.77e-04 | 507 | 45 | 8 | M48302 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT | 2.07e-04 | 7 | 45 | 2 | M27199 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_E2_TO_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY | 2.07e-04 | 7 | 45 | 2 | M47805 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 2.43e-04 | 96 | 45 | 4 | M39834 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CLASSICAL_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION | 2.76e-04 | 8 | 45 | 2 | M47872 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_LIGAND_UBIQUITYLATION | 3.54e-04 | 9 | 45 | 2 | M47866 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 3.93e-04 | 45 | 45 | 3 | M39571 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 4.19e-04 | 46 | 45 | 3 | MM15971 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 4.41e-04 | 10 | 45 | 2 | M22040 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 4.41e-04 | 10 | 45 | 2 | MM1560 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 4.47e-04 | 47 | 45 | 3 | M7946 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 5.33e-04 | 118 | 45 | 4 | MM15588 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 5.38e-04 | 11 | 45 | 2 | M15422 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | 5.68e-04 | 120 | 45 | 4 | MM14982 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | 6.43e-04 | 124 | 45 | 4 | M27285 | |
| Pathway | BIOCARTA_HES_PATHWAY | 6.44e-04 | 12 | 45 | 2 | MM1562 | |
| Pathway | BIOCARTA_HES_PATHWAY | 6.44e-04 | 12 | 45 | 2 | M22042 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 6.44e-04 | 12 | 45 | 2 | MM1526 | |
| Pathway | BIOCARTA_CLASSIC_PATHWAY | 6.44e-04 | 12 | 45 | 2 | MM1368 | |
| Pathway | REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT | 6.73e-04 | 54 | 45 | 3 | MM14655 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 7.60e-04 | 13 | 45 | 2 | MM1347 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 7.60e-04 | 13 | 45 | 2 | M12950 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER | 8.30e-04 | 58 | 45 | 3 | M29616 | |
| Pathway | WP_COMPLEMENT_AND_COAGULATION_CASCADES | 8.30e-04 | 58 | 45 | 3 | M39649 | |
| Pathway | WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES | 8.72e-04 | 59 | 45 | 3 | M48343 | |
| Pathway | PID_NOTCH_PATHWAY | 8.72e-04 | 59 | 45 | 3 | M17 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 8.85e-04 | 14 | 45 | 2 | MM1458 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 8.85e-04 | 14 | 45 | 2 | M6487 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 9.61e-04 | 61 | 45 | 3 | M39540 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 1.02e-03 | 15 | 45 | 2 | MM14922 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER | 1.02e-03 | 15 | 45 | 2 | M27202 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 1.02e-03 | 15 | 45 | 2 | M27161 | |
| Pathway | BIOCARTA_CLASSIC_PATHWAY | 1.02e-03 | 15 | 45 | 2 | M7146 | |
| Pathway | KEGG_MEDICUS_VARIANT_NOTCH_OVEREXPRESSION_TO_NOTCH_SIGNALING_PATHWAY | 1.16e-03 | 16 | 45 | 2 | M47424 | |
| Pathway | PID_INTEGRIN5_PATHWAY | 1.31e-03 | 17 | 45 | 2 | M212 | |
| Pathway | WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION | 1.31e-03 | 17 | 45 | 2 | M39389 | |
| Pathway | KEGG_COMPLEMENT_AND_COAGULATION_CASCADES | 1.37e-03 | 69 | 45 | 3 | M16894 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 1.48e-03 | 18 | 45 | 2 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 1.48e-03 | 18 | 45 | 2 | MM14882 | |
| Pathway | REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS | 1.49e-03 | 71 | 45 | 3 | M1078 | |
| Pathway | WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS | 1.65e-03 | 19 | 45 | 2 | M39473 | |
| Pathway | REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS | 1.65e-03 | 19 | 45 | 2 | M27221 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 1.65e-03 | 19 | 45 | 2 | MM15594 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 1.68e-03 | 74 | 45 | 3 | M160 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 1.68e-03 | 74 | 45 | 3 | M616 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 1.70e-03 | 161 | 45 | 4 | M27871 | |
| Pathway | BIOCARTA_AMI_PATHWAY | 1.83e-03 | 20 | 45 | 2 | M15394 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 1.83e-03 | 20 | 45 | 2 | MM15061 | |
| Pathway | REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT | 2.10e-03 | 80 | 45 | 3 | M6121 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 2.26e-03 | 82 | 45 | 3 | MM15922 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 2.42e-03 | 23 | 45 | 2 | M15997 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 2.42e-03 | 23 | 45 | 2 | MM1427 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 2.42e-03 | 84 | 45 | 3 | M3228 | |
| Pathway | REACTOME_COMPLEMENT_CASCADE | 2.42e-03 | 84 | 45 | 3 | MM14653 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 2.42e-03 | 84 | 45 | 3 | M7098 | |
| Pathway | REACTOME_NOTCH3_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 2.85e-03 | 25 | 45 | 2 | M27879 | |
| Pathway | WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE | 2.85e-03 | 25 | 45 | 2 | M39713 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 3.57e-03 | 28 | 45 | 2 | M6177 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 4.09e-03 | 30 | 45 | 2 | M27772 | |
| Pathway | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | 4.37e-03 | 31 | 45 | 2 | M592 | |
| Pathway | REACTOME_SIGNALING_BY_BMP | 4.37e-03 | 31 | 45 | 2 | M1662 | |
| Pathway | REACTOME_SIGNALING_BY_BMP | 4.37e-03 | 31 | 45 | 2 | MM14789 | |
| Pathway | WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY | 4.66e-03 | 106 | 45 | 3 | M42535 | |
| Pathway | WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME | 4.66e-03 | 106 | 45 | 3 | M40052 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 4.96e-03 | 502 | 45 | 6 | MM14537 | |
| Pathway | REACTOME_COMPLEMENT_CASCADE | 5.85e-03 | 115 | 45 | 3 | M19752 | |
| Pathway | WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES | 6.28e-03 | 118 | 45 | 3 | M39852 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 6.51e-03 | 38 | 45 | 2 | MM14969 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 6.51e-03 | 38 | 45 | 2 | MM14874 | |
| Pathway | REACTOME_CLASSICAL_ANTIBODY_MEDIATED_COMPLEMENT_ACTIVATION | 6.85e-03 | 39 | 45 | 2 | MM17212 | |
| Pubmed | 1.17e-09 | 10 | 55 | 4 | 9415455 | ||
| Pubmed | Basal lamina molecules are concentrated in myogenic regions of the mouse limb bud. | 3.96e-09 | 13 | 55 | 4 | 9833687 | |
| Pubmed | 1.31e-08 | 17 | 55 | 4 | 39315665 | ||
| Pubmed | Canonical Notch ligands and Fringes have distinct effects on NOTCH1 and NOTCH2. | 1.50e-08 | 4 | 55 | 3 | 32820046 | |
| Pubmed | Fibroblastic niches prime T cell alloimmunity through Delta-like Notch ligands. | 1.50e-08 | 4 | 55 | 3 | 28319044 | |
| Pubmed | Expression patterns of Notch receptors and their ligands Jagged and Delta in human placenta. | 3.73e-08 | 5 | 55 | 3 | 21726900 | |
| Pubmed | 3.73e-08 | 5 | 55 | 3 | 30181175 | ||
| Pubmed | 7.46e-08 | 6 | 55 | 3 | 10878362 | ||
| Pubmed | 7.46e-08 | 6 | 55 | 3 | 19217325 | ||
| Pubmed | Promotion of tumor cell migration by extracellular matrix proteins in human pancreatic cancer. | 7.46e-08 | 6 | 55 | 3 | 19893454 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 7.58e-08 | 135 | 55 | 6 | 28675934 | |
| Pubmed | Substrate specificities of recombinant mannan-binding lectin-associated serine proteases-1 and -2. | 1.30e-07 | 7 | 55 | 3 | 11527969 | |
| Pubmed | 1.30e-07 | 7 | 55 | 3 | 32060138 | ||
| Pubmed | Regulation of monocyte cell fate by blood vessels mediated by Notch signalling. | 1.30e-07 | 7 | 55 | 3 | 27576369 | |
| Pubmed | Hypoplastic basement membrane of the lens anlage in the inheritable lens aplastic mouse (lap mouse). | 1.30e-07 | 7 | 55 | 3 | 10716744 | |
| Pubmed | 1.30e-07 | 7 | 55 | 3 | 30289388 | ||
| Pubmed | 1.59e-07 | 153 | 55 | 6 | 25037231 | ||
| Pubmed | 2.08e-07 | 8 | 55 | 3 | 3997552 | ||
| Pubmed | 2.08e-07 | 8 | 55 | 3 | 1383086 | ||
| Pubmed | Molecular properties of wild-type and mutant betaIG-H3 proteins. | 2.08e-07 | 8 | 55 | 3 | 11867580 | |
| Pubmed | 2.59e-07 | 86 | 55 | 5 | 35103284 | ||
| Pubmed | 2.67e-07 | 167 | 55 | 6 | 22159717 | ||
| Pubmed | 3.12e-07 | 9 | 55 | 3 | 16245338 | ||
| Pubmed | 3.12e-07 | 9 | 55 | 3 | 12101409 | ||
| Pubmed | 3.52e-07 | 175 | 55 | 6 | 28071719 | ||
| Pubmed | Spatiotemporal expression of Notch receptors and ligands in developing mouse placenta. | 4.46e-07 | 10 | 55 | 3 | 23665443 | |
| Pubmed | 4.46e-07 | 10 | 55 | 3 | 24015274 | ||
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 4.74e-07 | 97 | 55 | 5 | 27559042 | |
| Pubmed | 5.51e-07 | 100 | 55 | 5 | 24859004 | ||
| Pubmed | Binding of mouse and human fibulin-2 to extracellular matrix ligands. | 6.12e-07 | 11 | 55 | 3 | 7500359 | |
| Pubmed | 8.15e-07 | 12 | 55 | 3 | 26794322 | ||
| Pubmed | Matrilin-2 interacts with itself and with other extracellular matrix proteins. | 8.15e-07 | 12 | 55 | 3 | 12180907 | |
| Pubmed | 8.15e-07 | 12 | 55 | 3 | 15465494 | ||
| Pubmed | 1.03e-06 | 48 | 55 | 4 | 35247391 | ||
| Pubmed | Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. | 1.06e-06 | 13 | 55 | 3 | 11578869 | |
| Pubmed | 1.06e-06 | 13 | 55 | 3 | 18708576 | ||
| Pubmed | 1.22e-06 | 50 | 55 | 4 | 27510977 | ||
| Pubmed | 1.35e-06 | 14 | 55 | 3 | 14757642 | ||
| Pubmed | 1.68e-06 | 15 | 55 | 3 | 12971992 | ||
| Pubmed | 1.68e-06 | 15 | 55 | 3 | 10625553 | ||
| Pubmed | 1.68e-06 | 15 | 55 | 3 | 9264260 | ||
| Pubmed | Expression of Notch pathway components in fetal and adult mouse small intestine. | 2.07e-06 | 16 | 55 | 3 | 12617809 | |
| Pubmed | 2.07e-06 | 16 | 55 | 3 | 19233133 | ||
| Pubmed | 2.07e-06 | 16 | 55 | 3 | 17273555 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 6981115 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 14660750 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 19037100 | ||
| Pubmed | Suppression of Th2 cell development by Notch ligands Delta1 and Delta4. | 2.46e-06 | 2 | 55 | 2 | 18209061 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 16393955 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 20548034 | ||
| Pubmed | Loss of Axin2 results in impaired heart valve maturation and subsequent myxomatous valve disease. | 2.46e-06 | 2 | 55 | 2 | 28069701 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 34424299 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 11035934 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 22782528 | ||
| Pubmed | DLL1- and DLL4-Mediated Notch Signaling Is Essential for Adult Pancreatic Islet Homeostasis. | 2.46e-06 | 2 | 55 | 2 | 32029480 | |
| Pubmed | Delta-like 1 is necessary for the generation of marginal zone B cells but not T cells in vivo. | 2.46e-06 | 2 | 55 | 2 | 15146182 | |
| Pubmed | Induction of T-cell development by Delta-like 4-expressing fibroblasts. | 2.46e-06 | 2 | 55 | 2 | 23988616 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 15728481 | ||
| Pubmed | Fibrillin-1 microfibril deposition is dependent on fibronectin assembly. | 2.46e-06 | 2 | 55 | 2 | 18653538 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 24867584 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 31934853 | ||
| Pubmed | Complex contributions of fibronectin to initiation and maturation of microfibrils. | 2.46e-06 | 2 | 55 | 2 | 24070235 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 25041739 | ||
| Pubmed | 2.50e-06 | 17 | 55 | 3 | 18694942 | ||
| Pubmed | Segmental expression of Notch and Hairy genes in nephrogenesis. | 2.50e-06 | 17 | 55 | 3 | 15821257 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 2.68e-06 | 248 | 55 | 6 | 24006456 | |
| Pubmed | 3.00e-06 | 18 | 55 | 3 | 18093989 | ||
| Pubmed | ADAMTS18-fibronectin interaction regulates the morphology of liver sinusoidal endothelial cells. | 3.00e-06 | 18 | 55 | 3 | 39040056 | |
| Pubmed | 3.00e-06 | 18 | 55 | 3 | 15689374 | ||
| Pubmed | 3.56e-06 | 19 | 55 | 3 | 20335360 | ||
| Pubmed | 3.56e-06 | 19 | 55 | 3 | 16518823 | ||
| Pubmed | 3.56e-06 | 19 | 55 | 3 | 25691540 | ||
| Pubmed | 3.58e-06 | 146 | 55 | 5 | 27068509 | ||
| Pubmed | Mutations in the NOTCH pathway regulator MIB1 cause left ventricular noncompaction cardiomyopathy. | 4.19e-06 | 20 | 55 | 3 | 23314057 | |
| Pubmed | Tie2 regulates endocardial sprouting and myocardial trabeculation. | 4.23e-06 | 68 | 55 | 4 | 31112136 | |
| Pubmed | 4.88e-06 | 21 | 55 | 3 | 28656980 | ||
| Pubmed | 5.64e-06 | 22 | 55 | 3 | 28334989 | ||
| Pubmed | 5.64e-06 | 22 | 55 | 3 | 21750033 | ||
| Pubmed | Epicardial function of canonical Wnt-, Hedgehog-, Fgfr1/2-, and Pdgfra-signalling. | 5.64e-06 | 22 | 55 | 3 | 24000064 | |
| Pubmed | 6.48e-06 | 23 | 55 | 3 | 14701881 | ||
| Pubmed | Lunatic Fringe-mediated Notch signaling is required for lung alveogenesis. | 6.48e-06 | 23 | 55 | 3 | 19897741 | |
| Pubmed | 6.48e-06 | 23 | 55 | 3 | 24337118 | ||
| Pubmed | 6.48e-06 | 23 | 55 | 3 | 36239412 | ||
| Pubmed | Helicobacter pylori Infection of Gastric Epithelial Cells Affects NOTCH Pathway In Vitro. | 7.36e-06 | 3 | 55 | 2 | 27073072 | |
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 3025878 | ||
| Pubmed | Identification of an Altered Matrix Signature in Kidney Aging and Disease. | 7.36e-06 | 3 | 55 | 2 | 34049963 | |
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 12527891 | ||
| Pubmed | C1q binding to surface-bound IgG is stabilized by C1r2s2 proteases. | 7.36e-06 | 3 | 55 | 2 | 34155115 | |
| Pubmed | Notch signaling confers antigen-presenting cell functions on mast cells. | 7.36e-06 | 3 | 55 | 2 | 19130928 | |
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 12684674 | ||
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 36514952 | ||
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 20008834 | ||
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 22919069 | ||
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 33351914 | ||
| Pubmed | KLF13 restrains Dll4-muscular Notch2 axis to improve the muscle atrophy. | 7.36e-06 | 3 | 55 | 2 | 38973459 | |
| Pubmed | Jagged2 acts as a Delta-like Notch ligand during early hematopoietic cell fate decisions. | 7.36e-06 | 3 | 55 | 2 | 21372153 | |
| Pubmed | T/B lineage choice occurs prior to intrathymic Notch signaling. | 7.36e-06 | 3 | 55 | 2 | 15845899 | |
| Pubmed | Lack of Delta like 1 and 4 expressions in nude thymus anlages. | 7.36e-06 | 3 | 55 | 2 | 16095582 | |
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 11823422 | ||
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 30578652 | ||
| Interaction | DCN interactions | 8.39e-08 | 43 | 52 | 5 | int:DCN | |
| Interaction | C1S interactions | 1.92e-06 | 10 | 52 | 3 | int:C1S | |
| Interaction | FBLN2 interactions | 2.52e-05 | 66 | 52 | 4 | int:FBLN2 | |
| Interaction | TGFBI interactions | 3.58e-05 | 25 | 52 | 3 | int:TGFBI | |
| Interaction | COL4A2 interactions | 4.18e-05 | 75 | 52 | 4 | int:COL4A2 | |
| Cytoband | 19q13.1 | 2.01e-03 | 55 | 55 | 2 | 19q13.1 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.97e-04 | 57 | 36 | 3 | 1179 | |
| GeneFamily | Complement system|Sushi domain containing | 2.33e-03 | 36 | 36 | 2 | 492 | |
| GeneFamily | Collagens | 3.78e-03 | 46 | 36 | 2 | 490 | |
| GeneFamily | Endogenous ligands | 1.15e-02 | 237 | 36 | 3 | 542 | |
| GeneFamily | Keratin associated proteins | 1.99e-02 | 109 | 36 | 2 | 619 | |
| Coexpression | NABA_CORE_MATRISOME | COL4A1 ZP1 COL4A3 FBN1 FN1 OTOGL MATN3 LAMA2 RSPO2 LTBP2 TECTA COLQ | 3.31e-13 | 270 | 55 | 12 | MM17057 |
| Coexpression | NABA_MATRISOME | COL4A1 ZP1 COL4A3 MASP1 SCUBE1 FBN1 FN1 BMP10 OTOGL CCBE1 MATN3 LAMA2 RSPO2 C1QA CHRDL1 LTBP2 TECTA COLQ | 1.09e-12 | 1008 | 55 | 18 | MM17056 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 7.33e-12 | 191 | 55 | 10 | MM17059 | |
| Coexpression | NABA_CORE_MATRISOME | COL4A1 ZP1 COL4A3 FBN1 FN1 MATN3 LAMA2 RSPO2 LTBP2 TECTA COLQ | 1.10e-11 | 275 | 55 | 11 | M5884 |
| Coexpression | NABA_MATRISOME | COL4A1 ZP1 COL4A3 MASP1 SCUBE1 FBN1 FN1 BMP10 CCBE1 MATN3 LAMA2 RSPO2 C1QA CHRDL1 LTBP2 TECTA COLQ | 1.75e-11 | 1026 | 55 | 17 | M5889 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.87e-10 | 196 | 55 | 9 | M3008 | |
| Coexpression | BOQUEST_STEM_CELL_UP | 7.06e-08 | 261 | 55 | 8 | M1834 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | COL4A1 SCUBE1 FBN1 FN1 OTOGL CCBE1 MATN3 CHRDL1 C1R LTBP2 ZFP36 | 4.64e-07 | 767 | 55 | 11 | M39209 |
| Coexpression | NABA_BASEMENT_MEMBRANES | 1.50e-06 | 40 | 55 | 4 | M5887 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 3.26e-06 | 194 | 55 | 6 | M39122 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 3.89e-06 | 200 | 55 | 6 | M5930 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 4.80e-06 | 16 | 55 | 3 | MM1296 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 4.80e-06 | 16 | 55 | 3 | M2207 | |
| Coexpression | HOSHIDA_LIVER_CANCER_SUBCLASS_S1 | 9.78e-06 | 235 | 55 | 6 | M5311 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 1.55e-05 | 385 | 55 | 7 | M39264 | |
| Coexpression | VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP | 3.61e-05 | 178 | 55 | 5 | M17079 | |
| Coexpression | CUI_DEVELOPING_HEART_VASCULAR_ENDOTHELIAL_CELL | 5.30e-05 | 193 | 55 | 5 | M39321 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 5.46e-05 | 35 | 55 | 3 | MM17054 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 5.46e-05 | 35 | 55 | 3 | M11788 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 5.94e-05 | 36 | 55 | 3 | MM1212 | |
| Coexpression | GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_60H_DN | 6.28e-05 | 200 | 55 | 5 | M9657 | |
| Coexpression | GSE20715_WT_VS_TLR4_KO_24H_OZONE_LUNG_DN | 6.28e-05 | 200 | 55 | 5 | M4354 | |
| Coexpression | BROWNE_HCMV_INFECTION_48HR_DN | 6.44e-05 | 482 | 55 | 7 | M12144 | |
| Coexpression | PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP | 8.09e-05 | 211 | 55 | 5 | M12225 | |
| Coexpression | VANHARANTA_UTERINE_FIBROID_UP | 1.09e-04 | 44 | 55 | 3 | M18274 | |
| Coexpression | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP | 1.33e-04 | 47 | 55 | 3 | M7585 | |
| Coexpression | TRAVAGLINI_LUNG_ALVEOLAR_EPITHELIAL_TYPE_1_CELL | 1.66e-04 | 391 | 55 | 6 | M41659 | |
| Coexpression | HALLMARK_COAGULATION | 2.04e-04 | 138 | 55 | 4 | M5946 | |
| Coexpression | DESCARTES_FETAL_LUNG_STROMAL_CELLS | 2.24e-04 | 56 | 55 | 3 | M40248 | |
| Coexpression | DESCARTES_FETAL_KIDNEY_MESANGIAL_CELLS | 2.24e-04 | 56 | 55 | 3 | M40224 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPERIC | 2.39e-04 | 795 | 55 | 8 | M39050 | |
| Coexpression | DESCARTES_FETAL_KIDNEY_STROMAL_CELLS | 2.53e-04 | 146 | 55 | 4 | M40222 | |
| Coexpression | RUBENSTEIN_SKELETAL_MUSCLE_FBN1_FAP_CELLS | 3.49e-04 | 289 | 55 | 5 | M41750 | |
| Coexpression | MA_RAT_AGING_DN | 3.66e-04 | 161 | 55 | 4 | M46419 | |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP | 3.84e-04 | 163 | 55 | 4 | M12112 | |
| Coexpression | DESCARTES_FETAL_ADRENAL_LYMPHOID_CELLS | 3.93e-04 | 164 | 55 | 4 | M40154 | |
| Coexpression | MA_RAT_AGING_DN | 4.50e-04 | 170 | 55 | 4 | MM16097 | |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 4.71e-04 | 72 | 55 | 3 | MM1131 | |
| CoexpressionAtlas | placenta | 2.16e-05 | 349 | 52 | 7 | placenta | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 5.59e-05 | 85 | 52 | 4 | GSM777067_100 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 6.12e-05 | 87 | 52 | 4 | GSM777050_100 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 9.36e-05 | 97 | 52 | 4 | GSM777046_100 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_BronchSmoothMuscl_top-relative-expression-ranked_1000 | 1.14e-04 | 981 | 52 | 10 | PCBC_ctl_BronchSmoothMuscl_1000 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 1.15e-04 | 455 | 52 | 7 | GSM777055_500 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_500_k-means-cluster#3 | 1.47e-04 | 206 | 52 | 5 | JC_fibro_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#5 | 1.68e-04 | 212 | 52 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_500 | 1.82e-04 | 490 | 52 | 7 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_500 | 2.26e-04 | 356 | 52 | 6 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_500 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.74e-04 | 369 | 52 | 6 | gudmap_kidney_adult_RenalCapsule_k2_1000 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#1_top-relative-expression-ranked_500 | 2.98e-04 | 240 | 52 | 5 | gudmap_kidney_adult_RenalCapsule_k1_500 | |
| CoexpressionAtlas | alpha beta T cells, T.DP69+.Th, 4+ 8+ TCRlo/int 69+, Thymus, avg-3 | 3.69e-04 | 57 | 52 | 3 | GSM399394_100 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.22e-12 | 181 | 55 | 9 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.40e-12 | 195 | 55 | 9 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.75e-12 | 198 | 55 | 9 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.01e-12 | 200 | 55 | 9 | 8ab0051544ea32eb8b3f7f8ba7582deaf8bf26c0 | |
| ToppCell | -Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 5.57e-11 | 179 | 55 | 8 | e4224b2e9c4ae7da62cf670adf811f4112c7d060 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.56e-11 | 186 | 55 | 8 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.02e-10 | 193 | 55 | 8 | 5bee7abc550ddaa28cbb3b9ecaf6b924ab175de0 | |
| ToppCell | 21-Trachea-Mesenchymal|Trachea / Age, Tissue, Lineage and Cell class | 1.06e-10 | 194 | 55 | 8 | 749dd8113ef260e00facac09de9861d61725124a | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.10e-10 | 195 | 55 | 8 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.10e-10 | 195 | 55 | 8 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.10e-10 | 195 | 55 | 8 | 1236dc60288c7dd91868e86e9174a2dacd3b11b3 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.15e-10 | 196 | 55 | 8 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 1.20e-10 | 197 | 55 | 8 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.24e-10 | 198 | 55 | 8 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.30e-10 | 199 | 55 | 8 | 7a227c239afdaebcac84644d9b2653a5f1a4be71 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.30e-10 | 199 | 55 | 8 | 66a79732caf2f04c09b4d9832377aa01ca477677 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-10 | 200 | 55 | 8 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Biopsy_IPF-Mesenchymal-Myofibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 1.35e-10 | 200 | 55 | 8 | c2c6f687c49ba790174b27c7b8b084af30b34c86 | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D231|Adult / Lineage, Cell type, age group and donor | 1.32e-09 | 164 | 55 | 7 | 2ba57dce5f69a88f0d1e450b9780425e2d9ca7d4 | |
| ToppCell | -Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 1.62e-09 | 169 | 55 | 7 | 8ebe9a88111c53a09c25a7b6a164a0a17880458d | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.07e-09 | 175 | 55 | 7 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 2.15e-09 | 176 | 55 | 7 | 510f9a14dc1c151d24d079e0cc004cdf4f86336c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.52e-09 | 180 | 55 | 7 | 01f2e5d96016823482f89ba503d007d4bd88eeac | |
| ToppCell | facs-Skin-nan-24m-Mesenchymal|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-09 | 185 | 55 | 7 | 8433a337625ff8398520e223ef92bf9bb0beb14c | |
| ToppCell | facs-Skin-nan-24m-Mesenchymal-fibroblast|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-09 | 185 | 55 | 7 | 049d793d043d5d434f143025de49dd210d18756c | |
| ToppCell | facs-Skin-nan-24m-Mesenchymal-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-09 | 185 | 55 | 7 | 63200c42565eea596f9b00728e70e544b8d50a7f | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 3.28e-09 | 187 | 55 | 7 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 3.67e-09 | 190 | 55 | 7 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.94e-09 | 192 | 55 | 7 | b9e4585bea280ca0ae159f0c6a2bf7b88a15a6e6 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.23e-09 | 194 | 55 | 7 | 8fae8061b350336299aa81f378e07deadbd55123 | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 4.23e-09 | 194 | 55 | 7 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 4.23e-09 | 194 | 55 | 7 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | 21-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 4.23e-09 | 194 | 55 | 7 | 8fc98d2c9d94f3bc6292265e20ab71c4f1f37bb3 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.23e-09 | 194 | 55 | 7 | 4d7d24390fdb379f943ddcc70a63f23955e10163 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.39e-09 | 195 | 55 | 7 | 78cfde21dde4b877fc76c8b0d5ddaabe44b912d7 | |
| ToppCell | ASK428-Mesenchymal|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.39e-09 | 195 | 55 | 7 | 2b156163975d9a3d3fda1402acd9831d0fdc9e25 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 4.39e-09 | 195 | 55 | 7 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 4.39e-09 | 195 | 55 | 7 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | ASK428-Mesenchymal-Fibroblast|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.39e-09 | 195 | 55 | 7 | c269c0d894a0f55da6495b59d4b9abb9f68df684 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.39e-09 | 195 | 55 | 7 | f5e91ce20a7ce528dc4c1a968c7bf096bf45c528 | |
| ToppCell | COPD-Stromal-Myofibroblast|COPD / Disease state, Lineage and Cell class | 4.55e-09 | 196 | 55 | 7 | af206bb5bbb8b604a6212acd79878bcc3d326cec | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.55e-09 | 196 | 55 | 7 | 9737a5f006d37b549f281e1863aca558e1e4dc99 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.55e-09 | 196 | 55 | 7 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.55e-09 | 196 | 55 | 7 | cecf82cd5e0a3835d655f5e7478578674a63ce25 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.55e-09 | 196 | 55 | 7 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.71e-09 | 197 | 55 | 7 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 4.71e-09 | 197 | 55 | 7 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | COPD-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 4.71e-09 | 197 | 55 | 7 | d51f484b4e01ac64233950d0b97fa88825ea1dbb | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.71e-09 | 197 | 55 | 7 | 13896ec65ccda0b928c91d41112dc01b480036b7 | |
| ToppCell | tumor_Lung-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lung / Location, Cell class and cell subclass | 4.88e-09 | 198 | 55 | 7 | 2d7842f352273b6b823c86eb548b9f4a4cddf0ae | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.88e-09 | 198 | 55 | 7 | 300d7cc56207d77168390fa1ffcbcf76767b1b80 | |
| ToppCell | distal-mesenchymal-Myofibroblast-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.88e-09 | 198 | 55 | 7 | beef5075ba6dcd4d0a447bc4e57efcaf2e93c546 | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 4.88e-09 | 198 | 55 | 7 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | COVID-19-kidney-Fibroblast-2|kidney / Disease (COVID-19 only), tissue and cell type | 4.88e-09 | 198 | 55 | 7 | ca26ca460856b1faaa3e83766da6abdf63af2b51 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 4.88e-09 | 198 | 55 | 7 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Fibroblastic-Fibro_myofibroblast|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.88e-09 | 198 | 55 | 7 | 08d393853e195a7eacace454153e425a273e2d23 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.88e-09 | 198 | 55 | 7 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 5.05e-09 | 199 | 55 | 7 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Fibroblasts|World / lung cells shred on cell class, cell subclass, sample id | 5.05e-09 | 199 | 55 | 7 | e2b6752fcabd5249a166486ae6796f2c97c1fcaf | |
| ToppCell | ASK452-Mesenchymal-Fibroblast|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.05e-09 | 199 | 55 | 7 | 4d0bf2a4bd97e5a3bfe4570a201cc21bb9c4c1f6 | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.05e-09 | 199 | 55 | 7 | 3835452e4848d7f7dd8651c17b746b271ef39688 | |
| ToppCell | ASK452-Mesenchymal|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.05e-09 | 199 | 55 | 7 | 93e85e3731a9ece9aee3eb82c5dfdad331ee62d6 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.05e-09 | 199 | 55 | 7 | 0019cfaa586a450c2e4952d1184a540561c8d0ba | |
| ToppCell | COVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type | 5.05e-09 | 199 | 55 | 7 | 9503646ff1ad248181146ce767e9d12e882ec3bd | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.23e-09 | 200 | 55 | 7 | 8978867bf69c830b1e48cac2ad6b512dbe60f149 | |
| ToppCell | cellseq-Mesenchymal|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.23e-09 | 200 | 55 | 7 | 238285fc372ce2e5e4341fc3084a3a833bf4a0a6 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-2,_SCARA5|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 5.23e-09 | 200 | 55 | 7 | 2022df85df94ab8cbb4e80e3fe9894c01051c5e0 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.23e-09 | 200 | 55 | 7 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.23e-09 | 200 | 55 | 7 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.23e-09 | 200 | 55 | 7 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 5.23e-09 | 200 | 55 | 7 | 69b41f5fb370aa8840a9ad7919d03ef1e57d1b5b | |
| ToppCell | proximal-mesenchymal-Adventitial_Fibroblast|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.23e-09 | 200 | 55 | 7 | 58c5870030192b337e7d883044948634fcd17d2c | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 5.23e-09 | 200 | 55 | 7 | 4f7e26b27bd51c32420ed8c2f52d070aee542159 | |
| ToppCell | proximal-mesenchymal-Adventitial_Fibroblast-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.23e-09 | 200 | 55 | 7 | 05486d86868f6a93429226063cca270f00dd8714 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Myofibroblasts|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 5.23e-09 | 200 | 55 | 7 | ca777a7d001848f6d01c613ff2bda7e4f3e20521 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.23e-09 | 200 | 55 | 7 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | proximal-3-mesenchymal-Adventitial_Fibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.23e-09 | 200 | 55 | 7 | 869d45b71efd395d050873db5fee2ed0443d5e6f | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.23e-09 | 200 | 55 | 7 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.23e-09 | 200 | 55 | 7 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.23e-09 | 200 | 55 | 7 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_myofibroblast|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.23e-09 | 200 | 55 | 7 | 251fd2923f108cd2086961d897244b392c32ad54 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.23e-09 | 200 | 55 | 7 | cb31cfcfa8e6d6cc610c4c22e97bc009dd8a9e7c | |
| ToppCell | cellseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.23e-09 | 200 | 55 | 7 | b441b3771fb7d9ee7b7a104afc35e466aace2da2 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.23e-09 | 200 | 55 | 7 | fd92d8250c6ad1e8bb46b303ac37f8dcf80387d8 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-3|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.23e-09 | 200 | 55 | 7 | 07641f476cb1a131c2a50258b88cc13bb38c8379 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-3|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 5.23e-09 | 200 | 55 | 7 | 343fa6ba1f52d816d2e41466f674ff8360aecd81 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.23e-09 | 200 | 55 | 7 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.23e-09 | 200 | 55 | 7 | 5a87bb8eb1c6bd2fbc357e1528e15ba1c0051438 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-3-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.23e-09 | 200 | 55 | 7 | d0c00cdd52c2e001aec9b935f4e981ba77d0386a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.40e-08 | 152 | 55 | 6 | 621e9b33cd3bb1c7b7d0633069f286b203e3d9c0 | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 4.45e-08 | 159 | 55 | 6 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.35e-08 | 173 | 55 | 6 | 1f16d47f5548e257e4b17f8070c5619780a9c5fd | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.86e-08 | 175 | 55 | 6 | 795a6564d5a75ffd35d39f5274b9e8d28708bbc8 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.13e-08 | 176 | 55 | 6 | 2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.13e-08 | 176 | 55 | 6 | f33ab41d121b59d871ad7d48ca021524a027d2ef | |
| ToppCell | -Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 8.99e-08 | 179 | 55 | 6 | 10fadbaa1b6d21cbf9f354d717cc4c225619f4fd | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G|390C / Donor, Lineage, Cell class and subclass (all cells) | 9.29e-08 | 180 | 55 | 6 | 137fc14859c89e1ecd98bee388bb58c04b835847 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G-|390C / Donor, Lineage, Cell class and subclass (all cells) | 9.29e-08 | 180 | 55 | 6 | cd6790de050151fedfa2c5ea6ad58b72665414b2 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.60e-08 | 181 | 55 | 6 | 9c157de9d3403e092c907599f2a2c16db5b21131 | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 9.60e-08 | 181 | 55 | 6 | bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9 | |
| Computational | ECM and collagens. | 5.43e-05 | 225 | 33 | 6 | MODULE_47 | |
| Disease | Weill-Marchesani syndrome | 9.13e-06 | 3 | 52 | 2 | C0265313 | |
| Disease | Weill-Marchesani Syndrome, Autosomal Dominant | 9.13e-06 | 3 | 52 | 2 | C1869115 | |
| Disease | Weill-Marchesani Syndrome, Autosomal Recessive | 9.13e-06 | 3 | 52 | 2 | C1869114 | |
| Disease | Weill-Marchesani syndrome | 1.82e-05 | 4 | 52 | 2 | cv:C0265313 | |
| Disease | Weill-Marchesani syndrome (is_implicated_in) | 1.82e-05 | 4 | 52 | 2 | DOID:0050475 (is_implicated_in) | |
| Disease | Marfan syndrome (implicated_via_orthology) | 1.36e-04 | 10 | 52 | 2 | DOID:14323 (implicated_via_orthology) | |
| Disease | Marfan Syndrome | 1.66e-04 | 11 | 52 | 2 | C0024796 | |
| Disease | collagen disease (implicated_via_orthology) | 1.99e-04 | 12 | 52 | 2 | DOID:854 (implicated_via_orthology) | |
| Disease | iron deficiency anemia (biomarker_via_orthology) | 2.35e-04 | 13 | 52 | 2 | DOID:11758 (biomarker_via_orthology) | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 3.85e-04 | 80 | 52 | 3 | DOID:12930 (implicated_via_orthology) | |
| Disease | Hyalinosis, Segmental Glomerular | 1.12e-03 | 28 | 52 | 2 | C0086432 | |
| Disease | cancer (implicated_via_orthology) | 1.28e-03 | 268 | 52 | 4 | DOID:162 (implicated_via_orthology) | |
| Disease | spontaneous coronary artery dissection | 1.37e-03 | 31 | 52 | 2 | EFO_0010820 | |
| Disease | Squamous cell carcinoma | 1.38e-03 | 124 | 52 | 3 | C0007137 | |
| Disease | macrophage inflammatory protein 1a measurement | 1.46e-03 | 32 | 52 | 2 | EFO_0008218 | |
| Disease | Complement deficiency disease | 1.55e-03 | 33 | 52 | 2 | C0272242 | |
| Disease | Heart Failure, Diastolic | 1.55e-03 | 33 | 52 | 2 | C1135196 | |
| Disease | refractive error, self reported educational attainment | 1.65e-03 | 34 | 52 | 2 | EFO_0004784, MONDO_0004892 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NHSGRFVCTVPGYYY | 146 | P02745 | |
| SPFLECHGRGTCNYY | 1611 | Q01955 | |
| HCEPCTGYQYQVDRY | 541 | Q14833 | |
| DQEDGYHCLCPPGYY | 341 | Q9NR61 | |
| TQRVHCFCPGGSEYY | 536 | Q9Y2T1 | |
| HNYVGGYFCSCRPGY | 166 | P00736 | |
| APFIECHGRGTCNYY | 1611 | P02462 | |
| YFIAGCGPAVCYYAV | 31 | Q9Y442 | |
| NTHYCQCPLGYTGSY | 1131 | Q04721 | |
| LPGSYGDLQCTQYCY | 431 | Q9Y215 | |
| ASYHCDCYPGYTLNE | 411 | O15232 | |
| LGCRGYYFVHELCAY | 106 | O95665 | |
| VIVDCRYPYEYEGGH | 436 | P30305 | |
| YEGQYCERCAPGYTG | 1501 | P24043 | |
| GYEAYECRGVCNYPL | 346 | O95393 | |
| YIGGCCGFEPYHIRA | 286 | Q9H2M3 | |
| HPYLEPYGLVYCVNC | 51 | Q9BU40 | |
| HRYVCECARGYGGPN | 501 | O00548 | |
| GCYHNGVYYEPEQTV | 1586 | Q9Y6R7 | |
| HGVRYQCYCYGRGIG | 581 | P02751 | |
| GGYRCSCPQGYLQHY | 2586 | P35555 | |
| FGRVLCTCYPGYRYD | 106 | Q6UXH8 | |
| YQQGDFGYCPRVYCE | 101 | P67870 | |
| GNYSCPHYKGTIVVY | 606 | Q6ZMT9 | |
| VPGYVCLCNPGFHYD | 1506 | Q14767 | |
| IGGYYCSCRFGYILH | 161 | P48740 | |
| YGGYRYSCCHPSCYG | 41 | Q3SYF9 | |
| YPGVCSTTSYRTHCY | 11 | Q3LI83 | |
| LSCYQVYCGRYINGH | 1146 | Q9UBN7 | |
| PGSFQCLCHRGYILY | 341 | Q8IWY4 | |
| QITVYHYDGGPCYRC | 211 | O95396 | |
| YYPCPAVCTIYGDRH | 941 | Q3ZCN5 | |
| SSAYGLVHCCYEIYG | 756 | O95602 | |
| SVPGVYCLCVLYHGY | 36 | O60880 | |
| VQYHGYCPDCDTRYN | 211 | Q569H4 | |
| DCTYSIHVYPGYGIE | 201 | Q6UXD5 | |
| YGECLHSCPSGYYGH | 71 | Q6UXX9 | |
| YNVEGSFYCQCVPGY | 86 | Q9BY15 | |
| SFYCQCVPGYRLHSG | 91 | Q9BY15 | |
| YVKEHYPNGVCTVYG | 131 | P47755 | |
| LPHSCGCYSDGKYYE | 1421 | O75443 | |
| FGGYYCPCHGSHYDA | 231 | P47985 | |
| CYDNTREVPCYYGNT | 261 | P60852 | |
| YHPQYGFYCAYGRPC | 71 | P40200 | |
| NCSRSYYYPVCGDGV | 506 | Q6ZQN7 | |
| GHYYCYAREGAARPA | 861 | Q9P2H5 | |
| YLQGRCPYGSRCHFI | 151 | P26651 | |
| VDYGLAYRYCPEGVH | 196 | Q99986 | |
| NCYASYGLCGIHYID | 676 | Q8WUA4 | |
| YCGPFEYEVGYCERL | 141 | Q8NHP8 | |
| RLCRQGYACPYYHNS | 226 | Q9C0B0 | |
| VFYKCGECGSYYNPH | 186 | Q8N2I2 | |
| HTGEKPYQCQYCEYR | 566 | P08048 | |
| GIFPYQCEYCDYGAI | 186 | Q9C0D4 | |
| RIHYCDYPGCTKVYT | 371 | Q13887 | |
| KLYCGHCYYQTVVTP | 131 | P53667 |